Data Strategy: Speeding Up Phase II to Slow Down Phase III?

Sept. 1, 2011 - PRLog -- Cambridge Healthtech Institute (CHI), the conference organizer of Accelerating Proof of Concept: Clinical Success Driven by Sciences and Strategy, has added these presentations that are scheduled on October 4 from 11:00 am – 5:20 pm.

Soluble Ligand PK/PD Modeling and Its Application to the Development of a Monoclonal Antibody
Thomas A. Puchalski, Pharm.D., Director, Oncology PK/PD , Pharmacokinetic and Pharmacometrics Group, Biologics Clinical Pharmacology, Centocor R&D, a division of Johnson & Johnson Pharmaceutical Research & Development, LLC

Acceleration in PoC, Speed or Confidence?
Xiaoyin (Frank) Fan, M.S., Ph.D., Director, Biometrics, Vertex Pharmaceuticals

How Systematic Indication Expansion can Accelerate Proof of Concept
Aris Persidis, Ph.D., President & CoFounder, Biovista

Pharmacometrics and PoC: Preventative Care for Drug Development
Thaddeus Grasela, Pharm.D., Ph.D., Adjunct Professor, University at Buffalo

The Utility of Decision Analysis in Early Clinical Development
Eyas Abu-Raddad, Ph.D., Research Advisor, PK/PD Chorus, Eli Lilly & Co

Evaluating Clinical Research Sites, Let’s Get Scientific about Data Quality
Neil K. Singla, M.D., CEO, Lotus Clinical Research, LLC

EXPERT PANEL: Partnerships, Collaborations and Consortiums: What Makes These Successful Models?
Moderator: Russell Linderman, Ph.D., Executive Director, Research Science & Technology PGRD, Pfizer Inc.

For more information and to register, please visit http://www.healthtech.com/pfc. Those that register by September 2 will save up to $200.

To inquire about sponsoring and/or exhibiting, contact Carol Dinerstein, 781-972-5471, dinerstein@healthtech.com.

Writers and editors are encouraged to attend. To request a press pass, contact Tracey Fielding at tfielding@healthtech.com.

About Cambridge Healthtech Institute (www.chicorporate.com)

Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech’s Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.

Contact:
James Prudhomme
Cambridge Healthtech Institute
781-972-5400
jprudhomme@healthtech.com